Abstract
Radical thymectomy is the gold standard treatment for thymoma; in particular, completeness of surgical resection of a well-encapsulated thymoma and adequate margins are considered the most important prognostic factors. According to the International Thymic Malignancy Interest Group instructions, in fact, the thymus should be resected en bloc with its upper cervical poles and the surrounding mediastinal fat and through a no-touch surgical technique. For years, the open approaches have been considered the gold standard treatment for thymic masses, because of technical advantages and proved good oncological results. When applied to properly chosen patients on the basis of the tumor stage, dimension, and histology, minimally invasive approaches could be as effective as open ones in terms of long-term outcomes. To accomplish a minimally invasive thymoma resection, several minimally invasive techniques (transcervical, subxiphoid, thoracoscopic, and robotic) have been described, each presenting advantages and drawbacks. Moreover, when dealing with early stage neoplasms, many authors have proposed to perform the thymomectomy alone, not involving the rest of the thymic gland, but evidence is still imprecise and vague, and some studies have described a higher rate of local recurrence when using this technique. Finally, many studies suggest that surgeons with expertise in minimally invasive lymphadenectomy for lung cancer may easily endorse the idea of nodal dissection, to be performed at least in advanced thymomas involving neighboring structures, large masses, and thymic carcinomas.
Highlights
Thymic neoplasms and malignancies are relatively uncommon
Invasive thymoma and thymic carcinoma could be treated with multimodal therapy including induction or adjuvant chemo- or chemoradiotherapy associated with en-bloc surgical resection
When comparing robotic vs. video-assisted thoracic surgery (VATS) thymectomy, instead, the results show no differences in the two groups in terms of operative time, blood loss, length of hospital stay, intraoperative complications, and margin rates
Summary
Thymic neoplasms and malignancies are relatively uncommon. Approximately 90% of the tumors of the thymus are thymoma, accounting for about 0.2%-1.5% of all cancers. Recent studies have reported similar oncological outcomes for early-stage thymoma resections performed both by open and minimally invasive approaches[50,51,52,53], the first one remains the gold standard treatment[19].
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.